Lymphedema

Tactile Systems Technology, Inc. Reports First Quarter 2024 Financial Results

Retrieved on: 
月曜日, 5月 6, 2024
Society for Vascular Surgery, Total, Cellulitis, Lymphedema, Webcast, Retirement, TCMD, Patient, Operating cost, Head, DME, Quality of life, Growth, Video game

MINNEAPOLIS, May 06, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2024.

Key Points: 
  • MINNEAPOLIS, May 06, 2024 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the first quarter ended March 31, 2024.
  • Gross profit in the first quarter of 2024 increased $2.0 million, or 5%, to $43.4 million, compared to $41.5 million in the first quarter of 2023.
  • Operating loss was $3.0 million in the first quarter of 2024, compared to $3.8 million in the first quarter of 2023.
  • Non-GAAP operating loss in the first quarter of 2024 was $1.7 million, compared to $2.2 million in the first quarter of 2023.

The Aesthetic Foundation Welcomes Dr. Onelio Garcia Jr. as President

Retrieved on: 
日曜日, 5月 5, 2024
Education, General surgery, Aesthetics, Jews, Surgeon, Patient safety, Child, Face, Aesthetic Surgery Journal, Saint Louis University, Journal, Breast cancer, Plastic, SSBI, Loyola University Medical Center, Woman, Lymphedema, McGuire family, DRS, Breast implant, Cleveland Clinic, Executive Committee, Mortality, Faculty, Calendar, University, Hospital, Safety, Publication, Private practice, Research, Trustee, Loma Linda University, Health, Student, Plastic surgery, Division, Synthetic control method, Elective surgery, Patient, Gravity anomaly, Clinical professor, Dentistry

VANCOUVER, BC, May 5, 2024 /PRNewswire/ -- The Aesthetic Foundation, formerly known as the Aesthetic Surgery Education and Research Foundation (ASERF), proudly announces the election of Dr. Onelio Garcia Jr. "Oni", as its new President. Dr. Garcia's appointment heralds an exciting chapter for The Foundation as it continues its mission to improve the safety and effectiveness of aesthetic surgery and medicine following a successful rebranding earlier this year.

Key Points: 
  • VANCOUVER, BC, May 5, 2024 /PRNewswire/ -- The Aesthetic Foundation, formerly known as the Aesthetic Surgery Education and Research Foundation (ASERF), proudly announces the election of Dr. Onelio Garcia Jr. "Oni", as its new President.
  • An official rollout of The Aesthetic Foundation rebranding was unveiled at The Aesthetic Meeting 2024 in Vancouver, Canada this week along with a new website, TheAestheticFoundation.org .
  • Dr. Garcia, a board-certified aesthetic plastic surgeon based in Miami, Florida brings a wealth of experience and a dedication to patient safety.
  • His leadership is poised to guide The Aesthetic Foundation in its renewed mission, building upon the strong foundation established over 30 years ago as ASERF.

Chang Gung Memorial Hospital, Linkou, Garners Two Prestigious International Awards for Its Outstanding Achievements

Retrieved on: 
火曜日, 4月 30, 2024
Investment, International Medical Center, Hospital, AI, Proton therapy, Bed, Internal medicine, Pediatrics, Lymphedema, EMRAM, Research, Organ transplantation, Patient safety, Gynaecology, Accreditation, HIMSS, Patient, JCI, Health, Multimedia, Patient satisfaction, Medicine, Nursing

TAOYUAN, April 29, 2024 /PRNewswire/ -- The Healthcare Asia Awards, a prestigious international recognition program, honors exceptional healthcare institutions across Asia for their pioneering achievements in healthcare innovation and patient care. On March 26th, at the 2024 Awards Ceremony held in Singapore, Chang Gung Memorial Hospital, Linkou, Taiwan, emerged victorious, capturing the coveted titles of Hospital of the Year - Taiwan and Smart Hospital Initiative of the Year - Taiwan.

Key Points: 
  • With over 30 departments, Chang Gung Memorial Hospital offers a broad spectrum of services, including internal medicine, surgery, gynecology, and pediatrics.
  • Chang Gung Memorial Hospital not only excels in medical technology and services but also prioritizes patient safety and compassionate care.
  • This year, the Healthcare Asia Awards acknowledged Chang Gung Memorial Hospital in Linkou for its exceptional leadership in medical services, research, and smart healthcare innovations.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/chang-gung-memorial-hospital-li...
    SOURCE Chang Gung Memorial Hospital, Linkou

AIROS Medical Names Darren Behuniak as Chief Operating Officer

Retrieved on: 
木曜日, 4月 11, 2024
Health Technology, Health, Cardiology, Medical Devices, Multimedia, Marketing, Lymphedema, AIROS, Social media

AIROS® Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy devices that treat lymphedema and venous complications, today announced it has named Darren M. Behuniak as its Chief Operating Officer.

Key Points: 
  • AIROS® Medical, Inc., a medical technology manufacturer and designer specializing in compression therapy devices that treat lymphedema and venous complications, today announced it has named Darren M. Behuniak as its Chief Operating Officer.
  • Behuniak is a co-founder of AIROS and has been serving as vice president of operations and marketing since the company’s founding in 2016.
  • View the full release here: https://www.businesswire.com/news/home/20240411794360/en/
    Behuniak is a founding partner of AIROS Medical and will expand his role as Chief Operating Officer.
  • “Darren has been a lynchpin at our organization and a key member of the management team since our inception seven years ago,” says Gerald Makoid, CEO and president of AIROS Medical.

United Breast Cancer Foundation's Mattress & Pink Bag Event Brings Breast Cancer Warriors to Warwick, Rhode Island April 27th

Retrieved on: 
木曜日, 4月 18, 2024
Volunteering, Clothing, Cancer, Princess, Hope, Sadness, Dream, Lymphedema, Skin care, Emotion, United Breast Cancer Foundation, Survivor, Confusion, Friends, Family, Patient, Comfort, Warwick Mall, Sleep, Breast cancer, Mattress, Nightclub

WARWICK, R.I., April 18, 2024 /PRNewswire-PRWeb/ -- United Breast Cancer Foundation (UBCF) is calling on volunteers and the Warwick, Rhode Island community to join us for a day dedicated to those battling breast cancer! The "Gifts of Comfort and Hope" Mattress & Pink Bag Event on Saturday, April 27th is being held at the Warwick Mall. The highly anticipated event will provide vital resources, thoughtful gifts and an uplifting experience for breast cancer warriors. This very special day is quickly approaching, so if you are a breast cancer patient or survivor, we encourage you to apply today and attend the event to feel the warmth and support blossoming this Spring!

Key Points: 
  • The "Gifts of Comfort and Hope" Mattress & Pink Bag Event on Saturday, April 27th is being held at the Warwick Mall.
  • The highly anticipated event will provide vital resources, thoughtful gifts and an uplifting experience for breast cancer warriors.
  • In collaboration with fellow breast cancer organization, Gloria Gemma Breast Cancer Resource Foundation, UBCF aims to provide a nurturing and restorative day for deserving individuals.
  • The UBCF Mattress and Pink Bag Event is open to all breast cancer patients and survivors.

ImpediMed to Present Chronic Breast Cancer-related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting

Retrieved on: 
木曜日, 4月 11, 2024
FDA, Cancer, American Cancer Society, Risk, Woman, Cleveland Clinic, Lymphedema, Research, Body composition, BIS, Patient, Society, Melanoma, MBA, Quality of life, Breast cancer, Medical imaging

CARLSBAD, Calif., April 11, 2024 /PRNewswire/ -- ImpediMed, a leader in medical technologies to clinically monitor and manage fluid and body composition, announced today that it will present new results from a breast cancer-related lymphedema study during a poster session at the American Society of Breast Surgeons (ASBrS) Annual Meeting in Orlando, FL on Friday, April 12, 2024.

Key Points: 
  • CARLSBAD, Calif., April 11, 2024 /PRNewswire/ -- ImpediMed , a leader in medical technologies to clinically monitor and manage fluid and body composition, announced today that it will present new results from a breast cancer-related lymphedema study during a poster session at the American Society of Breast Surgeons (ASBrS) Annual Meeting in Orlando, FL on Friday, April 12, 2024.
  • "Chronic breast cancer-related lymphedema can represent a risk to patients who have undergone breast cancer treatment with meaningful impact on their quality of life," said Chirag Shah, MD, Co-Director of the Comprehensive Breast Cancer Program, Cleveland Clinic, lead author of the study, and scientific adviser to ImpediMed.
  • ImpediMed Chief Medical Officer, Steven L. Chen, MD, MBA, one of the study's authors, will present the findings at ASBrS.
  • According to the American Cancer Society 58% of cancer patients diagnosed with breast cancer, melanoma, or pelvic area cancers are at risk for developing limb lymphedema, and over 80% of breast cancer patients are at risk.

MMI Receives FDA Authorization to Commercialize Symani® Surgical System in the U.S.

Retrieved on: 
月曜日, 4月 8, 2024
Technology, Medical Devices, Surgery, Hospitals, FDA, Health Technology, Hardware, Robotics, Health, Oncology, Freedom, Surgeon, Classification, Lymphedema, Filtration, Physician, Patient, Hospital, European, Platform supply vessel, Tremor, Blood, Wrist, Hand, Microsurgery, Food, Medicine, Dentistry

The FDA authorization makes the Symani Surgical System the only commercially available platform in the U.S. for reconstructive microsurgery.

Key Points: 
  • The FDA authorization makes the Symani Surgical System the only commercially available platform in the U.S. for reconstructive microsurgery.
  • “With the authorization from the FDA, our technology will expand its reach to pioneering hospitals in the U.S.
  • The Symani Surgical System provides advanced solutions for a range of open surgeries, including post-mastectomy breast cancer reconstruction, extremity reconstruction using free tissue transfer, and lymphatic system repair.
  • MMI plans to immediately launch the technology in the U.S.
    To learn more about MMI and the Symani Surgical System, visit MMI’s website here: https://mmimicro.com .

Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Outlook

Retrieved on: 
火曜日, 2月 20, 2024
Marketing, Lymphedema, Growth, Total, Patient, Tactile, Webcast, TCMD, Video game

Gross profit in the fourth quarter of 2023 increased $3.9 million, or 7.5%, to $56.0 million, compared to $52.1 million in the fourth quarter of 2022.

Key Points: 
  • Gross profit in the fourth quarter of 2023 increased $3.9 million, or 7.5%, to $56.0 million, compared to $52.1 million in the fourth quarter of 2022.
  • Operating income was $11.8 million in the fourth quarter of 2023, compared to $7.9 million in the fourth quarter of 2022.
  • Non-GAAP operating income in the fourth quarter of 2023 was $12.7 million, compared to $9.5 million in the fourth quarter of 2022.
  • Non-GAAP net income in the fourth quarter of 2023 was $8.9 million, compared to $5.9 million in the fourth quarter of 2022.

La Jolla Vein & Vascular Proudly Announces World Lymphedema Day Patient Education Event

Retrieved on: 
水曜日, 3月 6, 2024
Health, General Health, Caregiver, Multimedia, Education, Conditional sentence, Physician, Lymphedema, Quality of life, Learning, Patient, Lymphatic system, Nursing

La Jolla Vein & Vascular, a leading provider of vascular health services in the San Diego area, is excited to announce their upcoming event today, the World Lymphedema Day Patient Education Event.

Key Points: 
  • La Jolla Vein & Vascular, a leading provider of vascular health services in the San Diego area, is excited to announce their upcoming event today, the World Lymphedema Day Patient Education Event.
  • View the full release here: https://www.businesswire.com/news/home/20240306096183/en/
    La Jolla Vein & Vascular staff prepare for World Lymphedema Day Patient Education Event.
  • "We are thrilled to support World Lymphedema Day and hold this Patient Education Event as part of our ongoing commitment to improving vascular health and raising awareness about conditions such as lymphedema," said Dr. Nisha Bunke, Medical Director at La Jolla Vein & Vascular.
  • Don't miss this unique opportunity to participate in the World Lymphedema Day Patient Education Event on March 6, 2024, at La Jolla Vein & Vascular.

Koya Medical Announces Topline Results from Its Latest Trial on the Treatment of Lower Extremity Lymphedema at VENOUS2024

Retrieved on: 
水曜日, 3月 6, 2024
FDA, Lymphedema, Quality of life, Patient, Dayspring, Publication, MD

OAKLAND, Calif. and TAMPA, Fla., March 6, 2024 /PRNewswire/ -- Koya Medical, today announces topline results from its TEAYS trial.

Key Points: 
  • OAKLAND, Calif. and TAMPA, Fla., March 6, 2024 /PRNewswire/ -- Koya Medical, today announces topline results from its TEAYS trial.
  • TEAYS (NCT05507346) is a prospective multi-center, randomized cross-over study comparing lower extremity lymphedema treatment effectiveness of Dayspring®, Koya's non-pneumatic compression device (NPCD) with a traditional advanced pneumatic compression device (APCD).
  • The study met its primary endpoints, achieving statistically significant differences in limb volume reduction, improvement of quality of life, and treatment adherence, all favoring the Dayspring treatment arm over the APCD treatment arm.
  • The latest TEAYS trial results add to the growing body of evidence for Dayspring, which has had 7 prior publications to date.